Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) CAO Kristen Ambrose sold 289 shares of the business’s stock in a transaction on Tuesday, May 30th. The stock was sold at an average price of $329.82, for a total transaction of $95,317.98. Following the transaction, the chief accounting officer now directly owns 6,838 shares of the company’s […]
Westpark Capital assumed coverage on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Get Rating) in a report published on Thursday, The Fly reports. The brokerage issued a hold rating on the pharmaceutical company’s stock. VRTX has been the subject of a number of other research reports. Barclays boosted their target price on Vertex Pharmaceuticals from $342.00 […]
SVB Wealth LLC lessened its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 1.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,460 shares of the pharmaceutical company’s stock after selling 264 shares during the period. SVB […]
Tradewinds LLC. purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 14,056 shares of the pharmaceutical company’s stock, valued at approximately $554,000. Other institutional investors also recently bought and sold shares […]
Jag Capital Management LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 1.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 46,633 shares of the pharmaceutical company’s stock after purchasing an additional 545 shares during the […]